Orkambi: Children
(asked on 6th December 2016) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, for what reasons the Kalydeco form of Ivacaftor has been deemed unsuitable for use by children aged between two and five in England; what assessment he has made of its use by children in Scotland; and if he will make a statement.
This question was answered on 13th December 2016
On 4 December 2016, NHS England announced that ivacaftor would, in future, be commissioned according to its licensed indications for children between two and five.